Clinical trial
Salvage Treatment With Topotecan in Patients With Irinotecan-Refractory Small Cell Lung Cancer
NCT00502762 is registered in ClinicalTrials.gov with Gachon University Gil Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Salvage Treatment With Topotecan in Patients With Irinotecan-Refractory Small Cell Lung Cancer
- Lead sponsor
- Gachon University Gil Medical Center
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- September 30, 2004
- Completion date
- August 31, 2007
- Enrollment
- Not reported
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lung cancer, refractory to chemotherapy